New Autism Research Program: Big Pharma Profit Center with Taxpayers’ Help

Post from Gaia Health

The European Union has partnered with pharmaceutical corporations and Autism Speaks for the sole purpose of developing drugs to cram down the throats of autistics. Rather than doing honest research into the causes of this devastating condition, money is being poured into finding ways to suppress its symptoms.

A new organization, European Autism Interventions – A Multicentre Study for Developing New Medications  (EU-AIMS), has been formed to benefit Big Pharma’s bottom line at the expense of autistics. The plan is to simply accept that autism is here, in spite of its nonexistence or near nonexistence a few decades ago. The organization has no interest in autism prevention.

Project Goals

EU-AIMS states its goals as :

• To develop and validate “translation research approaches” for the advancement of novel therapies.
• To set new standards in research and clinical development to aid the drug discovery process.
• Development of sites across Europe for clinical trials on autism, and create an “interactive platform for ASD professionals and patients”.

Let’s examine those goals:

Translational Research

Translational research is a new concept that’s being pushed by Big Pharma, as can be seen in this definition given by the Wellcome Trust ,

Translational research helps turn early-stage innovations into new health products, advancing the innovation to the point where it becomes attractive for further development by the medical, pharmaceutical or biotechnology industries.

In other words, the goal of translational research is simply to bring more products to market more quickly. it is an attempt to streamline development of pharmaceutical drugs and bring them through the approval process more rapidly.

One must ask why this is a focus for treatment of autism. And why do they presume that it’s beneficial to autistics? The reality has been that drugs used for treating autistics, even though they’ve gone through a more extensive approval process, have proven to be harmful, not helpful. Why would an organization whose goal one would expect to benefit autistics choose to push such a plan?

Read the entire article here.